logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
5/7/2019 6:54:26 AM Merck Says BELSOMRA C-IV Meets Primary Efficacy Endpoint In Phase 3 Trial
4/30/2019 6:49:03 AM Merck Q1 GAAP EPS $1.12; Non-GAAP EPS $1.22
4/22/2019 6:49:51 AM Merck Says FDA Approved KEYTRUDA In Combination With Inlyta
4/4/2019 7:09:37 AM Myriad, AstraZeneca And Merck Expand Companion Diagnostic Partnership
4/2/2019 6:52:48 AM Merck Completes Tender Offer To Buy Immune Design
4/1/2019 8:41:39 AM Merck Reports First-time Presentation Of Results From Phase 3 KEYNOTE-189 Trial
4/1/2019 2:06:09 AM AstraZeneca Says Selumetinib Gets Breakthrough Therapy Designation
3/25/2019 10:57:34 AM S&P 500 Q4 Share Repurchases Increases 62.8% T-o-y To $223.0 Bln